IP Verse

Tillotts Pharma patent opposition analysis

Get complete Patent Opposition Report for Tillotts Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Tillotts Pharma

Explore patent oppositions filed by Tillotts Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP2461802	Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof	SOFAR	Feb 28, 2019
EP2611429	Mesalazine Tablet Having Improved Dissolution	DISPHAR	Nov 21, 2018
EP2552955	Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance	CHUGAI SEIYAKU KABUSHIKI KAISHA	Feb 5, 2018

Latest patents of Tillotts Pharma opposed by its competitors

Explore Tillotts Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3459528	Nov 23, 2022	Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering	1

Top competitors of Tillotts Pharma

CHUGAI SEIYAKU KABUSHIKI KAISHA

DISPHAR

HEIROTH